Finanzen von Ingevity Corp (NGVT)NGVTIngevity Corp

Ingevity Corporation (NGVT) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pavement Technologies product line, accounting for 19.3% of total sales, equivalent to $49.70M. Another important revenue stream is Industrial Specialties product line. Understanding this composition is critical for investors evaluating how NGVT navigates market cycles within the Diversified Chemicals industry.

Evaluating the bottom line, Ingevity Corporation maintains a gross margin of 44.25%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 29.74%, while the net margin is 12.67%. These profitability ratios, combined with a Return on Equity (ROE) of 30.07%, provide a clear picture of how effectively NGVT converts its operational activities into shareholder value.

In the context of the broader market, NGVT competes directly with industry leaders such as IOSP and HUN. With a market capitalization of $2.64B, it holds a leading position in the sector. When comparing efficiency, NGVT's gross margin of 44.25% stands against IOSP's 28.14% and HUN's 14.73%. Such benchmarking helps identify whether Ingevity Corporation is trading at a premium or discount relative to its financial performance.

Ingevity reported Q2 2026 sales of $314 million, a 5% year-over-year increase, and net income of $35.3 million, marking a significant recovery from previous losses. The gross margin for Q2 2026 was 44.25%, showing strong profitability despite challenges.